| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/19/2002 | EP1214063A1 Method of treating cancer using tetraethyl thiuram disulfide |
| 06/19/2002 | EP1214059A2 Surface modified particulate compositions of biologically active substances |
| 06/19/2002 | EP1214057A1 Vascular coating composition |
| 06/19/2002 | EP1214041A2 Combination therapy for the treatment of sepsis |
| 06/19/2002 | EP1214039A2 Methods and compositions for preventing and treating urinary tract disorders |
| 06/19/2002 | EP1214038A2 Methods and compositions for preventing and treating prostate disorders |
| 06/19/2002 | EP1213972A1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of "fast sugars" |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0892643B1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 06/19/2002 | EP0879062B1 Nucleic acid delivery vehicle |
| 06/19/2002 | EP0878201B1 Medicaments for the treatment or prevention of thrombocytopenia |
| 06/19/2002 | EP0814831B1 Medicaments for treatment of autoimmune diseases using interferon-tau |
| 06/19/2002 | EP0812421B1 Anti dna antibody detection involving telomeric dna sequence recognition and binding |
| 06/19/2002 | EP0772450B1 Methods for treating bleeding disorders |
| 06/19/2002 | EP0750504B1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus |
| 06/19/2002 | EP0714510B1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/19/2002 | EP0632817B1 Neurotrophic factors having altered receptor binding specificities |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354796A Medical preparations for treatment of alpha-galactosidase A deficiency |
| 06/19/2002 | CN1354792A Biosynthesis of foreign proteins using transformed microalgae |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354756A MEG-4 protein |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354676A Amnotetralin derivative for therapy of cardiovascular diseases |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354671A Method for inhibition of phospholamban activity for treatment of cardiac disease and heart failure |
| 06/19/2002 | CN1354670A Therapeutic agent comprising botulinum neurotoxin |
| 06/19/2002 | CN1354669A Pharmaceutical compositions of erythropoietin |
| 06/19/2002 | CN1354668A Isolated peptides which bind to HLA-B35 molecules |
| 06/19/2002 | CN1354253A Dilutus culex trypsase gene |
| 06/19/2002 | CN1354183A Tumor death induction ligand gene, gene expression protein and its preparation method |
| 06/19/2002 | CN1354015A Health-care product containing growth factor and its preparation method |
| 06/18/2002 | US6407222 Purified dna molecule codes |
| 06/18/2002 | US6407215 Antibodies to Mch2, an apoptotic cysteine protease |
| 06/18/2002 | US6407214 Engineering human antibodies |
| 06/18/2002 | US6407213 Method for making humanized antibodies |
| 06/18/2002 | US6407211 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/18/2002 | US6407209 Interferon-induced human protein in pure form, monoclonal antibodies thereto and test kits containing these antibodies |
| 06/18/2002 | US6407207 Amino acid sequences of proteins |
| 06/18/2002 | US6407205 Increasing fertility of vertibrates by administering lamprey luteinizing hormone releasing factor ii |
| 06/18/2002 | US6407204 Use of conantokins for producing analgesia or for neuoprotection |
| 06/18/2002 | US6407137 Dopamine analog amide |
| 06/18/2002 | US6407135 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor |
| 06/18/2002 | US6407134 Viricide for human t-cell leukemia/lymphoma virus |
| 06/18/2002 | US6407133 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 06/18/2002 | US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 06/18/2002 | US6407068 Administering ribosomal deactivating protein |
| 06/18/2002 | US6407067 Salts of thrombin inhibitors |
| 06/18/2002 | US6407066 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/18/2002 | US6407063 Tumor antigens and CTL clones isolated by a novel procedure |
| 06/18/2002 | US6407062 Polypeptide; antiproliferative agent |
| 06/18/2002 | US6407061 Absorption through nasal mucous membrane |
| 06/18/2002 | US6407060 Method for enhancing functional recovery following central nervous system ischemia or trauma |
| 06/18/2002 | US6407059 Conformationally constrained backbone cyclized peptide analogs |
| 06/18/2002 | US6407058 Phosphorylation of serine or threonine |
| 06/18/2002 | US6407057 Ovulation triggering drugs |
| 06/18/2002 | US6406902 Herpes virus proteinase and methods of assaying |
| 06/18/2002 | US6406900 Flea protease proteins, nucleic acid molecules and uses thereof |
| 06/18/2002 | US6406888 Cytokines, transcription, dna segments and termination |
| 06/18/2002 | US6406887 Antigens for binding to antibodies in tissues |
| 06/18/2002 | US6406885 Plant cell transformation vectors and dna code intimin |
| 06/18/2002 | US6406870 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes |
| 06/18/2002 | US6406867 Binding antibodies and proteins |
| 06/18/2002 | US6406866 Competitive binding to mammalian methadone specific opiod receptors in cell expression |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406859 DNA encoding a 5-HT 1F receptor and uses thereof |
| 06/18/2002 | US6406841 Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides |
| 06/18/2002 | US6406704 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/18/2002 | US6406701 Reducing the susceptibility of t lymphocytes to hiv infection |
| 06/18/2002 | US6406698 Pharmaceutical composition comprising serum amyloid P component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 06/18/2002 | US6406697 Amino acid sequence of ligand binding partner protein fused to c-terminus to n-terminus of immunoglobulin and cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods. |
| 06/18/2002 | US6406693 Killing tumor vascular endothelial cells by treatment with antibodies and binding with antigens |
| 06/18/2002 | US6406692 Infections for eyes treated with eye drops |
| 06/18/2002 | US6406688 Method of treating sepsis and ARDS with chemokine β-4 |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | US6406679 Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cells |
| 06/18/2002 | CA2315249C Biological properties of du-145 supernatant |
| 06/18/2002 | CA2241725C Growth-hormone secretagogues |
| 06/18/2002 | CA2098819C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions |
| 06/18/2002 | CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace |
| 06/18/2002 | CA1341369C Human interferon-.beta.2a and interferon-.beta.2b; vectors containing genes coding for said interferons: cell lines producing same and use of said interferons as pharmaceuticals |
| 06/13/2002 | WO2002046768A2 Proteins, genes and their use for diagnosis and treatment of chronic asthma |
| 06/13/2002 | WO2002046767A2 Diagnosis and treatment of alzheimer's disease |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | WO2002046473A1 Antisense modulation of damage-specific dna binding protein 2, p48 expression |
| 06/13/2002 | WO2002046466A2 Complexes of brca and stat polypeptides and methods of use in the detection and treatment of cancer |
| 06/13/2002 | WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | WO2002046449A2 Selection of catalytic nucleic acids targeted to infectious agents |
| 06/13/2002 | WO2002046433A2 Tnf-inducible promotors and methods for using them |
| 06/13/2002 | WO2002046430A2 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046424A2 Fibroblast growth factors |
| 06/13/2002 | WO2002046423A2 Protein derived from the melanin-concentrating hormone (mch), corresponding nucleic acids and their use for preparing medicines |
| 06/13/2002 | WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046417A2 Adipocyte complement related protein zacrp3x2 |
| 06/13/2002 | WO2002046415A2 Polynucleotide and polypeptide sequences of putative transporters and ion channells |